FAME 3
2022
Fractional flow reserve versus Angiography for Multivessel Evaluation 3
In 1,500 patients with 3-vessel coronary disease, FFR-guided PCI did not prove non-inferior for 1-year death, MI, stroke, or repeat revascularisation compared with CABG.
Result
Efficacy: MACCE (death, MI, stroke, or repeat revascularisation) at 1 yearHR 1.5 (95% CI 1.1-2.2)
Below 1 favours FFR-guided PCI, above 1 favours CABG.
- Absolute difference
- 3.7 points
- NNH
- 28
Absolute difference and NNH are derived from the event rates.
Also reported: Non-inferiority not met. At 5 years death/stroke/MI similar (16% vs 14%, HR 1.16, 95% CI 0.89-1.52).
- Subtopic
- FFR-guided PCI
- Design
- Multicentre RCT, non-inferiority
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2024 CCS
- Source
- Fearon WF, et al. N Engl J Med. 2022;386(2):128-37.doi 10.1056/NEJMoa2112299
Discussion & critique
1-year timepoint is short for a surgery-vs-PCI comparison and differences narrowed by 5 years. Reinforced CABG as preferred for higher-complexity 3-vessel disease while supporting PCI in lower SYNTAX-score anatomy.